Cincinnati Children's Hospital Medical Center
Comparative effectiveness trial leads to evidence-based care for childhood epilepsy
Published in Clinical Trials Week, March 15th, 2010
Published March 4 in the New England Journal of Medicine, data from the double-blind, randomized, comparative clinical trial fill a large information gap in the treatment of childhood absence epilepsy, also known as "petit mal" epilepsy. The research, which identifies important differences between drugs in seizure control and side effects, is expected to impact how physicians select and monitor initial therapy for children...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2010-03-15)
More Articles from Clinical Trials Week
- Elsevier Health Sciences
Dietary factors influence ovarian cancer survival rates - Emory University
Transplant drug preserves kidneys, avoids toxicity - International Association for the Study of Lung Cancer
Patient age not a factor in use of second-line therapy for lung cancer - JAMA and Archives Journals
Parents whose children are dying of cancer may consider hastening the process - Journal of the National Cancer Institute
State payer mandates to cover cancer trials offer heterogeneous protection for patients - University of North Carolina School of Medicine
Drug for advanced kidney cancer shrinks tumors prior to surgery - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
